MCID: VPM001
MIFTS: 37

Vipoma malady

Categories: Rare diseases, Gastrointestinal diseases, Endocrine diseases, Cancer diseases

Aliases & Classifications for Vipoma

About this section
Sources:
10Disease Ontology, 45NIH Rare Diseases, 47Novoseek, 12DISEASES, 51Orphanet, 36MeSH, 65UMLS, 42NCIt, 59SNOMED-CT, 28ICD10 via Orphanet, 37MESH via Orphanet, 66UMLS via Orphanet
See all MalaCards sources

Aliases & Descriptions for Vipoma:

Name: Vipoma 10 45 47 12 51 36 65
Pancreatic Cholera 51 65
Pancreatic Vipoma 45 65
Malignant Vasoactive Intestinal Peptide-Secreting Tumor 10
Watery Diarrhea-Hypokalemia-Achlorhydria Syndrome 51
Vasoactive Intestinal Peptide-Secreting Tumor 10
Vasoactive Intestinal Peptide-Producing Tumor 45
Vasoactive Intestinal Peptide Tumor 45
 
Diarrheogenic Islet Cell Tumor 51
Verner-Morrison Syndrome 51
Vip- Secreting Tumor 10
Vip-Secreting Tumor 51
Vipoma, Malignant 10
Malignant Vipoma 65
Wdha Syndrome 51

Characteristics:

Orphanet epidemiological data:

51
vipoma:
Inheritance: Not applicable; Prevalence: <1/1000000 (Europe); Age of onset: All ages; Age of death: any age

Classifications:



External Ids:

Disease Ontology10 DOID:5574
MeSH36 D003969
NCIt42 C26749
Orphanet51 97282
ICD10 via Orphanet28 E16.8
MESH via Orphanet37 D003969
UMLS via Orphanet66 C0011993
UMLS65 C0011993, C1881600

Summaries for Vipoma

About this section
NIH Rare Diseases:45 Vipoma is a rare cancer that develops within the pancreas. this tumor causes pancreatic cells to produce high levels of a hormone called vasoactive intestinal peptide (vip). the signs and symptoms of a vipoma include abdominal pain, flushing or redness of the face, nausea, watery diarrhea, weight loss, dehydration, and low blood potassium (hypokalemia). vipomas are usually diagnosed in adults around age 50. the cause of vipoma is unknown. treatment may include intravenous (iv) fluids to correct dehydration, medications such as octreotide to help control diarrhea, and surgery to remove the tumor. last updated: 3/8/2010

MalaCards based summary: Vipoma, also known as pancreatic cholera, is related to wdha syndrome and pancreatic vasoactive intestinal peptide producing tumor. An important gene associated with Vipoma is VIP (Vasoactive Intestinal Peptide), and among its related pathways are Transcription_Role of VDR in regulation of genes involved in osteoporosis and G alpha (s) signalling events. Affiliated tissues include pancreas, lung and prostate.

Wikipedia:68 A VIPoma (also known as Verner–Morrison syndrome, after the physicians who first described it) is a... more...

Related Diseases for Vipoma

About this section

Diseases related to Vipoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 161)
idRelated DiseaseScoreTop Affiliating Genes
1wdha syndrome12.4
2pancreatic vasoactive intestinal peptide producing tumor11.4
3ulcerative colitis10.6
4colitis10.6
5megacolon10.6
6toxic megacolon10.6
7pancreatic cholera10.4
8duodenal benign neoplasm10.2SST, VIP
9breast cancer10.2
10osmotic diarrhea10.2SST, VIP
11birdshot chorioretinopathy10.2SST, VIP
12cluttering10.2CALCA, VIP
13atrophic rhinitis10.2CALCA, VIP
14large cell carcinoma with rhabdoid phenotype10.2CALCA, SST
15paroxysmal nocturnal hemoglobinuria10.2CALCA, SST
16lipoadenoma10.2CALCA, SST
17gingival overgrowth10.1
18gingivitis10.1
19dystonia10.1
20endotheliitis10.1
21urinary system disease10.1CHGA, SST
22ischemic neuropathy10.1NTS, VIP
23alpha-methylacyl-coa racemase deficiency10.1SST, VIP
24craniodiaphyseal dysplasia10.1CALCA, SST
25villous adenocarcinoma10.1CHGA, SST
26kidney cancer10.1NTS, VIP
27parathyroid adenoma10.1CALCA, CHGA
28scabies10.1CALCA, CHGA
29myopathy with deficiency of iron-sulfur cluster assembly enzyme10.1CHGA, VIP
30colloid carcinoma of the pancreas10.1CHGA, SST
31corneal ectasia10.1CALCA, CHGA
32lung occult small cell carcinoma10.1CALCA, CHGA
33clivus chordoma10.0CALCA, CHGA
34papillary follicular thyroid adenocarcinoma10.0CHGA, SST
35non-syndromic x-linked intellectual disability10.0CHGA, SST
36organ system cancer10.0CALCA, CHGA
37neonatal respiratory failure10.0SST, VIP
38pancreatic cystadenocarcinoma10.0SCT, SST
39rheumatoid arthritis10.0
40lung cancer10.0
41prostate cancer10.0
42hepatocellular carcinoma10.0
43obesity10.0
44esophageal cancer10.0
45multiple myeloma10.0
46holt-oram syndrome10.0
47cryptorchidism10.0
48camurati-engelmann disease10.0
49mohr-tranebjaerg syndrome10.0
50arthritis10.0

Graphical network of the top 20 diseases related to Vipoma:



Diseases related to vipoma

Symptoms for Vipoma

About this section

Drugs & Therapeutics for Vipoma

About this section

Drugs for Vipoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 11)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Capecitabineapproved, investigationalPhase 21220154361-50-960953
Synonyms:
(1-(5-Deoxy-beta-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinyl)-carbamic acid pentyl ester
154361-50-9
158798-73-3
5'-Deoxy-5-fluoro-N-((pentyloxy)carbonyl)cytidine
5'-deoxy-5-fluoro-N-[(pentyloxy)carbonyl]cytidine
AC1L1U83
AC1Q4KU8
Ambap154361-50-9
C110904
C12650
C15H22FN3O6
CAPE
CAPECITABINE
CHEBI:31348
CHEMBL1773
CID60953
Capecitabin
Capecitabina
Capecitabine
Capecitabine (JAN/USAN/INN)
Capecitabine [USAN]
Capecitabinum
Capecitibine
Capiibine
Carbamic acid, (1-(5-deoxy-beta-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinyl)-, pentyl ester
Caxeta
 
D01223
DB01101
FT-0082472
HSDB 7656
LS-59070
MolPort-005-938-254
N(4)-Pentyloxycarbonyl-5'-deoxy-5-fluorocytidine
Pentyl 1-(5-deoxy-beta-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinecarbamate
Pentyl [1-(5-deoxy-beta-D-ribofuranosyl)-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl]carbamate
R-340
R340
RG-340
Ro 09-1978
Ro 09-1978/000
Ro-09-1978
Ro-09-1978/000
S1156_Selleck
UNII-6804DJ8Z9U
Xabine
Xeloda
Xeloda (TN)
Xeloda, Captabin, Capecitabine
ZINC03806413
capecitabina
capecitabine
capecitabinum
pentyl N-[1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyloxolan-2-yl]-5-fluoro-2-oxopyrimidin-4-yl]carbamate
2
Dacarbazineapproved, investigationalPhase 24114342-03-45351166
Synonyms:
(5E)-5-(dimethylaminohydrazinylidene)imidazole-4-carboxamide
(5Z)-5-(dimethylaminohydrazinylidene)imidazole-4-carboxamide
(Dimethyltriazeno)imidazolecarboxamide
37626-23-6
4(5)-(3,3-Dimethyl-1-triazeno)imidazole-4-carboxamide
4(5)-(3,3-Dimethyl-1-triazeno)imidazole-5(4)-carboxamide
4-(3,3-Dimethyl-1-triazeno)imidazole-5-carboxamide
4-(3,3-Dimethyltriazeno)imidazole-5-carboxamide
4-(5)-(3,3-Dimethyl-1-triazeno)imidazole-5(4)-carboxamide
4-(Dimethyltriazeno)imidazole-5-c arboxamide
4-(Dimethyltriazeno)imidazole-5-carboxamide
4-(or 5)-(3,3-Dimethyl-1-triazeno)imidazole-5(or 4)-carboxamide
4-(or 5)-(3,3-Dimethyl-1-triazeno)imidazole-5(or 4)-carboxamide
4-[(1E)-3,3-Dimethyltriaz-1-en-1-yl]-1H-imidazole-5-carboxamide
4-[3,3-dimethyltriaz-1-en-1-yl]-1H-imidazole-5-carboxamide
4342-03-4
5(or 4)-(dimethyltriazeno)imidazol e-4(or 5)-carboxamide
5(or 4)-(dimethyltriazeno)imidazole-4(or 5)-carboxamide
5-(3,3-Dimethyl-1-triazeno)imidazole-4-carboxamide
5-(3,3-Dimethyl-1-triazenyl)-1H-imidazole-4-carboxamide
5-(3,3-Dimethyl-1-triazenyl)imidazole-4-carboxamide
5-(3,3-Dimethyltri azeno)imidazole-4-carboxamide
5-(3,3-Dimethyltriazeno)-imidazole-4-carbamide
5-(3,3-Dimethyltriazeno)imidazole-4-carboxamide
5-(3,3-dimethyltriaz-1-en-1-yl)-1H-imidazole-4-carboxamide
5-(Dimethyltriazeno)-4-imidazolecarboxamide
5-(Dimethyltriazeno)imidazole-4-carboxamide
5-(Dimethyltriazeno)imidazole-4-carboximide
5-(dimethylaminohydrazinylidene)imidazole-4-carboxamide
5-[3,3-Dimethyl-1-triazenyl]imidazole-4-carboxamide
94361-71-4
AC1NQXVV
AC1NS01W
AC1NS4BN
AI3-52825
BPBio1_000428
BRD-K35520305-001-07-8
BSPBio_000388
BSPBio_002091
Biocarbazin
Biocarbazine
Biocarbazine R
C6H10N6O
CAS-891986
CCRIS 190
CHEBI:4305
CHEMBL476
CID5281007
CID5351166
CID5353562
Carboxamide, Dimethyl Imidazole
D00288
D003606
D2390_SIGMA
D3634
DB00851
DIC
DTCI
DTIC
DTIC Dome
DTIC, DTIC-Dome, Dacarbazine
DTIC-Dome
DTICDome
DTIE
Dacarbazin
Dacarbazina
Dacarbazine
Dacarbazine (JAN/USP/INN)
Dacarbazine [USAN:INN:BAN:JAN]
Dacarbazino
Dacarbazino [INN-Spanish]
Dacarbazinum
Dacarbazinum [INN-Latin]
 
Dacatic
Decarbazine
Deticene
Di-me-triazenoimidazolecarboxamide
Di-methyl-triazenoimidazolecarboxamide
Dimethyl Imidazole Carboxamide
Dimethyl Triazeno Imidazole Carboxamide
Dimethyltriazenoimidazolecarboxamide
DivK1c_000326
Dtic-Dome
Dtic-Dome (TN)
Dtic-dome (tn)
EINECS 224-396-1
HE1150000
HMS1569D10
HMS2090A20
HMS2091I20
HMS501A08
HSDB 3219
I06-2280
I14-1659
ICDMT
ICDT
IDI1_000326
Imidazole Carboxamide
Imidazole Carboxamide, Dimethyl
Imidazole carboxamide
KBio1_000326
KBio2_001364
KBio2_003932
KBio2_006500
KBio3_001311
KBioGR_000896
KBioSS_001364
LS-119
MLS001332543
MLS001332544
MolPort-003-666-153
MolPort-003-846-120
MolPort-006-709-420
NCGC00016986-01
NCGC00091861-01
NCGC00091861-02
NCGC00091861-03
NCGC00091861-04
NCI-C04717
NCI60_004053
NCIMech_000261
NINDS_000326
NIOSH/HE1150000
NPFAPI-05
NSC 45388
NSC-45388
NSC45388
Prestwick0_000574
Prestwick1_000574
Prestwick2_000574
Prestwick3_000574
Prestwick_904
S1221_Selleck
SMP2_000251
SMR000857131
SPBio_001075
SPBio_002607
SPECTRUM1500218
ST51014976
Spectrum2_001148
Spectrum3_000366
Spectrum4_000308
Spectrum5_000823
Spectrum_000884
UNII-7GR28W0FJI
WLN: T5M CNJ DVZ ENUNN1&1
dacarbazine
3
Temozolomideapproved, investigationalPhase 266285622-93-15394
Synonyms:
3,4-Dihydro-3-methyl-4-oxoimidazo(5,1-d)-1,2,3,5-tetrazine-8-carboxamide
3,4-Dihydro-3-methyl-4-oxoimidazo(5,1-d)-as-tetrazine-8-carboxamide
3,4-dihydro-3-Methyl-4-oxoimidazo(5,1-D)-1,2,3,5-tetrazine-8-carboxamide
3,4-dihydro-3-Methyl-4-oxoimidazo(5,1-D)-as-tetrazine-8-carboxamide
3-Methyl-4-oxo-3,4-dihydroimidazo(5,1-D)(1,2,3,5)tetrazine-8-carboxamide
3-Methyl-4-oxo-3,4-dihydroimidazo(5,1-d)(1,2,3,5)tetrazine-8-carboxamide
3-Methyl-4-oxo-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetraazine-8-carboxamide
3-methyl-4-oxo-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide
3-methyl-4-oxoimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide
8-Carbamoyl-3-methylimidazo(5,1-D)-1,2,3,5-tetrazin-4(3H)-one
8-Carbamoyl-3-methylimidazo(5,1-d)-1,2,3,5-tetrazin-4(3H)-one
85622-93-1
AC-758
AC1L1K9B
BIDD:GT0204
BRN 5547136
Bio-0147
C047246
C6H6N6O2
CCRG 81045
CCRG-81045
CCRIS 8996
CHEBI:153686
CHEMBL810
CID5394
CPD000466338
D06067
DB00853
Essex brand of temozolomide
HMS2051O12
HMS2090B08
I06-0149
I14-1943
LS-80558
M B 39831
M & B 39831
M&B 39831
M&B-39831
 
M-39831
MB 39831
MLS000759447
MLS001424028
MLS002701861
Methazolastone
NCGC00167429-01
NCGC00167429-02
NCI60_003316
NSC 362856
NSC-362856
NSC362856
SAM001246636
SMR000466338
STK623541
Sch 52365
Sch-52365
Schering brand of temozolomide
Schering-Plough brand of temozolomide
TL8005593
TMZ
TMZ-Bioshuttle
Temodal
Temodal (TN)
Temodar
Temozolamide
Temozolodida
Temozolodida [Spanish]
Temozolomid
Temozolomida
Temozolomide
Temozolomide (JAN/USAN/INN)
Temozolomide [INN:BAN]
Temozolomidum
Temozolomidum [Latin]
Témozolomide
UNII-YF1K15M17Y
ZINC01482184
m & b 39831
temozolomide
4
Epothilone Bexperimental, investigationalPhase 267152044-54-746936553
Synonyms:
EPO 906
 
EPO906
patupilone
5Antineoplastic Agents, AlkylatingPhase 23406
6Antimetabolites, AntineoplasticPhase 25770
7AntimetabolitesPhase 29454
8EpothilonesPhase 2114
9Tubulin ModulatorsPhase 24279
10Alkylating AgentsPhase 23582
11Antimitotic AgentsPhase 24296

Interventional clinical trials:

idNameStatusNCT IDPhase
1EPO906 in Carcinoid and Other Neuroendocrine TumorsCompletedNCT00050349Phase 2
2Capecitabine and Temozolomide for Neuroendocrine CancersCompletedNCT00869050Phase 2
3Gastroenteral-Pancreatic Neuroendocrine Tumors in TaiwanEnrolling by invitationNCT02102893

Search NIH Clinical Center for Vipoma


Cochrane evidence based reviews: vipoma

Genetic Tests for Vipoma

About this section

Anatomical Context for Vipoma

About this section

MalaCards organs/tissues related to Vipoma:

33
Pancreas, Lung, Prostate, Colon, Cortex, Heart, Endothelial

Animal Models for Vipoma or affiliated genes

About this section

Publications for Vipoma

About this section

Articles related to Vipoma:

(show top 50)    (show all 97)
idTitleAuthorsYear
1
Differential diagnosis and cancer staging of a unique case with multiple nodules in the lung - lung adenocarcinoma, metastasis of colon adenocarcinoma, and colon adenocarcinoma metastasizing to lung adenocarcinoma. (26273385)
2015
2
Pemphigoid gestationis with prepartum flare. (25039537)
2014
3
Home-based oral immunotherapy (OIT) with an intermittent loading protocol in children unlikely to outgrow egg allergy. (24572125)
2014
4
Impact of early evidence of atherosclerotic changes on early treatment in children with familial hypercholesterolemia. (24436424)
2014
5
Therapygenetics: anterior cingulate cortex-amygdala coupling is associated with 5-HTTLPR and treatment response in panic disorder with agoraphobia. (25223844)
2014
6
Expression of secretory leukocyte protease inhibitor detected by immunohistochemistry correlating with prognosis and metastasis in colorectal cancer. (25441765)
2014
7
Spire-1 contributes to the invadosome and its associated invasive properties. (24213528)
2014
8
MC1R major variants are a risk factor of sleep lines in Caucasian women. (23452314)
2014
9
Contrasting effects of A1 and A2b adenosine receptors on adipogenesis. (21730968)
2012
10
miR-122 regulates p53/Akt signalling and the chemotherapy-induced apoptosis in cutaneous T-cell lymphoma. (22235305)
2012
11
Reactive oxygen species-mediated activation of JNK and down-regulation of DAXX are critically involved in penta-O-galloyl-beta-d-glucose-induced apoptosis in chronic myeloid leukemia K562 cells. (22771329)
2012
12
The IDEAL study: investigation of dietary advice and lifestyle for women with borderline gestational diabetes: a randomised controlled trial - study protocol. (23046499)
2012
13
Acute liver failure: what is it? (22161273)
2012
14
Human synaptotagmin-II is not a high affinity receptor for botulinum neurotoxin B and G: increased therapeutic dosage and immunogenicity. (22265973)
2012
15
Oculocutaneous albinism type 3 (OCA3): analysis of two novel mutations in TYRP1 gene in two Chinese patients. (21739261)
2011
16
Induction of a 55 kDa acetylcholinesterase protein during apoptosis and its negative regulation by the Akt pathway. (21377978)
2011
17
Anaesthetic management of emergency cesarean section in a patient with holt oram syndrome. (21547188)
2010
18
Pin1 expression contributes to lung cancer: Prognosis and carcinogenesis. (20009523)
2010
19
Transient outward potassium channel regulation in healthy and diabetic hearts. (19234570)
2009
20
Human neural stem cells overexpressing glial cell line-derived neurotrophic factor in experimental cerebral hemorrhage. (19554035)
2009
21
Prognostic value of cyclin E and its relation to blood vessel invasion in rectal cancer]. (18344087)
2008
22
A combination vaccine against measles, mumps, rubella and varicella. (18536786)
2008
23
Cellular distribution of vascular endothelial growth factor A (VEGFA) and B (VEGFB) and VEGF receptors 1 and 2 in focal cortical dysplasia type IIB. (18317782)
2008
24
Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial. (19095129)
2008
25
Amino-acid sequence motifs for PKC-mediated membrane trafficking of the inhibitory killer Ig-like receptor. (18301382)
2008
26
Activated N-formyl peptide receptor and high-affinity IgE receptor occupy common domains for signaling and internalization. (17267694)
2007
27
Fibroblast growth factor-23 (FGF23) in patients with transient hypoparathyroidism: its important role in serum phosphate regulation. (17464094)
2007
28
The binding and phosphorylation of Thr231 is critical for Tau's hyperphosphorylation and functional regulation by glycogen synthase kinase 3beta. (17680984)
2007
29
Structural basis for Gas6-Axl signalling. (16362042)
2006
30
Beta1-adrenergic receptor (Arg389Gly) polymorphism and response to bisoprolol in patients with chronic heart failure]. (17217681)
2006
31
Population distribution of high sensitivity C-reactive protein values in Aboriginal Australians: a comparison with other populations. (16405882)
2006
32
Intractable desquamative interstitial pneumonia in a tattooed man. (17043377)
2006
33
Up-regulation of PINCH in the stroma of oral squamous cell carcinoma predicts nodal metastasis. (16273248)
2005
34
Oxidative stress, chromatin remodeling and gene transcription in inflammation and chronic lung diseases. (12542980)
2003
35
Thr(118)Met amino acid substitution in the peripheral myelin protein 22 does not influence the clinical phenotype of Charcot-Marie-Tooth disease type 1A due to the 17p11.2-p12 duplication. (14502374)
2003
36
Preparation of liposome containing bacteriorhodopsin with natural preferred orientation of its transient photoresponse]. (12673397)
2003
37
Secondary holocord syringomyelia with spinal hemangioblastoma: a report of two cases. (12865521)
2003
38
Protection of the Cyp1a2(-/-) null mouse against uroporphyria and hepatic injury following exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. (11384210)
2001
39
Effect of labor induction on the expression of oxytocin receptor, cytochrome P450 aromatase, and estradiol receptor in the reproductive tract of the late-pregnant ewe. (10084953)
1999
40
Paget's disease of bone in Malta. A preliminary survey. (10599381)
1999
41
Chronic toxic encephalopathy in a painter exposed to mixed solvents. (10210698)
1999
42
The crystal structure of the monomeric human SOD mutant F50E/G51E/E133Q at atomic resolution. The enzyme mechanism revisited. (10329151)
1999
43
Retrovirus-mediated transfer of the human alpha-L-iduronidase cDNA into human hematopoietic progenitor cells leads to correction in trans of Hurler fibroblasts. (9425437)
1997
44
Gene structure and cDNA sequence identify the beaded filament protein CP49 as a highly divergent type I intermediate filament protein. (8636093)
1996
45
Unexpected binding mode of the sulfonamide fluorophore 5- dimethylamino-1-naphthalene sulfonamide to human carbonic anhydrase II. Implications for the development of a zinc biosensor. (8557623)
1996
46
Desmoid tumor of the ulna in a patient with neurofibromatosis. (8583048)
1995
47
Immunochemical characterization of L-isoaspartyl-protein carboxyl methyltransferase from mammalian tissues. (7639720)
1995
48
Full trisomy 22 in a malformed newborn female. (1952793)
1991
49
Role of gastrin and gastrin receptors on the growth of a transplantable mouse colon carcinoma (MC-26) in BALB/c mice. (3004700)
1986
50
Cloacogenic carcinoma of the vagina. (761463)
1979

Variations for Vipoma

About this section

Expression for genes affiliated with Vipoma

About this section
Search GEO for disease gene expression data for Vipoma.

Pathways for genes affiliated with Vipoma

About this section

GO Terms for genes affiliated with Vipoma

About this section

Cellular components related to Vipoma according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1extracellular regionGO:00055768.7NTS, SCT, SST

Biological processes related to Vipoma according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1positive regulation of vasodilationGO:00459099.6CALCA, VIP
2response to yeastGO:00018789.6CALCA, VIP
3antifungal humoral responseGO:00197329.5CALCA, VIP
4antibacterial humoral responseGO:00197319.4CALCA, VIP
5defense response to Gram-negative bacteriumGO:00508299.3CALCA, CHGA
6cellular response to nerve growth factor stimulusGO:19900909.0CALCA, NTS

Sources for Vipoma

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet